Healthcare · Active clinical trials
In 2026, not a single active clinical trial was conducted in Mauritania — 0 units. This is a typical picture for West African countries, where pharmaceutical infrastructure and research institutes are just beginning to take shape. The lack of laboratory facilities, qualified personnel, and funding makes the country unattractive for international pharma companies. In terms of clinical trials, Mauritania shares 129th place with dozens of other states where this indicator is also zero.
Data for 2026 · unit: units
Position
#129 / 197
Mauritania world ranking
Country position on the scale from last to first place for this indicator.
MR
#129
#197#1
Trend
Change over time
Change in indicator over the available period.
2
1990
5
2000
1
2010
3
2020
1
2025
0
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Mauritania stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Mauritania — how much?
Based on 2026 data — 0 units. This is rank #129 out of 197 countries.
What is Mauritania's rank by Active clinical trials?
Mauritania ranks #129 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Mauritania?
Over the available period the indicator changed from 2 to 0 units.